Getting meningococcal B vaccines to the people most at risk

This year, we widened access to the meningococcal B vaccine to include free access for around 1,500 people who are at higher risk of contracting meningococcal disease.


The disease can lead to serious illnesses, including inflammation of your brain membranes (meningitis) and blood
poisoning (septicaemia). These illnesses can develop quickly over a few hours and can cause severe disability or even death. 

After consulting widely, we included close contacts of meningococcal cases and people who are at higher risk of contracting meningococcal B because they have reduced immune function due to certain health conditions.

This vaccine will protect those New Zealanders at higher risk of contracting meningococcal B, which on average causes more than half of all meningococcal cases each year.